BEND BIOSCIENCE Trademark

Trademark Overview


On Tuesday, September 10, 2024, a trademark application was filed for BEND BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the BEND BIOSCIENCE trademark a serial number of 98743466. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 19, 2025. This trademark is owned by CoreRx, Inc.. The BEND BIOSCIENCE trademark is filed in the Communication Services, Treatment & Processing of Materials Services, and Transportation & Storage Services categories with the following description:

Contract manufacturing services in the field of pharmaceuticals and pharmaceutical delivery systems to the order and specification of others

Contract packaging to the order and specification of others in the field of pharmaceuticals and pharmaceutical delivery systems; supply chain logistics and reverse logistics services for pharmaceuticals and pharmaceutical delivery systems, namely, storage, transportation and delivery of pharmaceuticals and pharmaceutical delivery systems for others; technology transfer services for pharmaceuticals manufacturing, namely, delivery of documents by non-electronic means in the nature of documents containing formulation, methods, and processes, delivery of drug product and machines for pharmaceutical manufacturing for others

Technology transfer services for pharmaceuticals manufacturing, namely, electronic delivery of documents containing formulation, methods, and processes
bend bioscience

General Information


Serial Number98743466
Word MarkBEND BIOSCIENCE
Filing DateTuesday, September 10, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, March 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesContract manufacturing services in the field of pharmaceuticals and pharmaceutical delivery systems to the order and specification of others
Goods and ServicesContract packaging to the order and specification of others in the field of pharmaceuticals and pharmaceutical delivery systems; supply chain logistics and reverse logistics services for pharmaceuticals and pharmaceutical delivery systems, namely, storage, transportation and delivery of pharmaceuticals and pharmaceutical delivery systems for others; technology transfer services for pharmaceuticals manufacturing, namely, delivery of documents by non-electronic means in the nature of documents containing formulation, methods, and processes, delivery of drug product and machines for pharmaceutical manufacturing for others
Goods and ServicesTechnology transfer services for pharmaceuticals manufacturing, namely, electronic delivery of documents containing formulation, methods, and processes

Classification Information


International Class038 - Services allowing people to communicate with another by a sensory means.
US Class Codes100, 101, 104
Class Status Code6 - Active
Class Status DateTuesday, September 10, 2024
Primary Code038
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, September 10, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateTuesday, September 10, 2024
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCoreRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressClearwater, FL 33760

Trademark Events


Event DateEvent Description
Tuesday, September 10, 2024NEW APPLICATION ENTERED
Friday, January 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 12, 2025ASSIGNED TO EXAMINER
Wednesday, March 19, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 19, 2025NON-FINAL ACTION WRITTEN